DILTIAZEM FOR USE IN THE TREATMENT OF MICROBIAL INFECTIONS

摘要

The present invention relates to diltiazem for its use as an activating agent for the expression of at least one gene encoding a type III interferon, in the prevention and / or treatment of infections with at least one pathogenic microorganism of epitheliums of the respiratory and / or intestinal tracts.